144 related articles for article (PubMed ID: 21277684)
21. Clinical application of gene expression profiling in breast cancer.
Sparano JA; Fazzari M; Kenny PA
Surg Oncol Clin N Am; 2010 Jul; 19(3):581-606. PubMed ID: 20620929
[TBL] [Abstract][Full Text] [Related]
22. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study.
Chanrion M; Fontaine H; Rodriguez C; Negre V; Bibeau F; Theillet C; Hénaut A; Darbon JM
BMC Cancer; 2007 Mar; 7():39. PubMed ID: 17338809
[TBL] [Abstract][Full Text] [Related]
23. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling: decoding breast cancer.
de Snoo F; Bender R; Glas A; Rutgers E
Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
[TBL] [Abstract][Full Text] [Related]
25. Transcriptomic signatures in breast cancer.
Fu J; Jeffrey SS
Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
[TBL] [Abstract][Full Text] [Related]
26. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
27. [Genomics and clinical research for breast cancer].
Bertucci F; Birnbaum D
Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
[TBL] [Abstract][Full Text] [Related]
28. Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.
Coutant C; Rouzier R; Qi Y; Lehmann-Che J; Bianchini G; Iwamoto T; Hortobagyi GN; Symmans WF; Uzan S; Andre F; de Thé H; Pusztai L
Clin Cancer Res; 2011 Apr; 17(8):2591-601. PubMed ID: 21248301
[TBL] [Abstract][Full Text] [Related]
29. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.
Albain KS; Paik S; van't Veer L
Breast; 2009 Oct; 18 Suppl 3():S141-5. PubMed ID: 19914534
[TBL] [Abstract][Full Text] [Related]
30. [Gene expression profiling using cDNA arrays and prognosis of breast cancer].
Bertucci F; Nasser V; Houlgatte R; Birnbaum D
Bull Cancer; 2002 Jun; 89(6):571-4. PubMed ID: 12135856
[TBL] [Abstract][Full Text] [Related]
31. The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response.
Loi S; Piccart M; Sotiriou C
Crit Rev Oncol Hematol; 2007 Mar; 61(3):187-94. PubMed ID: 17088071
[TBL] [Abstract][Full Text] [Related]
32. Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
Anguiano A; Potti A
Expert Rev Mol Diagn; 2007 Nov; 7(6):837-44. PubMed ID: 18020912
[TBL] [Abstract][Full Text] [Related]
33. Genomics in breast cancer-therapeutic implications.
Lønning PE; Sørlie T; Børresen-Dale AL
Nat Clin Pract Oncol; 2005 Jan; 2(1):26-33. PubMed ID: 16264853
[TBL] [Abstract][Full Text] [Related]
34. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
Brenton JD; Carey LA; Ahmed AA; Caldas C
J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060
[TBL] [Abstract][Full Text] [Related]
35. The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
Straver ME; Glas AM; Hannemann J; Wesseling J; van de Vijver MJ; Rutgers EJ; Vrancken Peeters MJ; van Tinteren H; Van't Veer LJ; Rodenhuis S
Breast Cancer Res Treat; 2010 Feb; 119(3):551-8. PubMed ID: 19214742
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic implications of advances in breast cancer biology].
Bertucci F; Gonçalves A; Maraninchi D
Rev Prat; 2004 Apr; 54(8):865-70. PubMed ID: 15274460
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome profiling in clinical breast cancer: from 3D culture models to prognostic signatures.
Fournier MV; Martin KJ
J Cell Physiol; 2006 Dec; 209(3):625-30. PubMed ID: 17001673
[TBL] [Abstract][Full Text] [Related]
38. Triple-negative breast cancer.
Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
[TBL] [Abstract][Full Text] [Related]
39. International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'.
Tavtigian SV; Pierotti MA; Børresen-Dale AL
Breast Cancer Res; 2006; 8(6):303. PubMed ID: 17096863
[TBL] [Abstract][Full Text] [Related]
40. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
Weigelt B; Baehner FL; Reis-Filho JS
J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
